Your Notifications
All done, no notifications

About Dr. Professor Liu Shuangyou

  • Professor Liu Shuangyou is a haematology specialist and serves as Head of the Twelfth Ward in the Department of General Haematology.
  • She holds a Doctor of Medicine degree from Heidelberg University, Germany, and has extensive clinical experience in the diagnosis and treatment of refractory and recurrent hematologic malignancies.
  • Professor Liu’s clinical and research focus is particularly centred on CAR-T cell immunotherapy and related translational and clinical research.
  • She has made significant contributions to the field through her research publications and active participation in major international haematology conferences, reflecting her strong academic engagement and commitment to advancing hematologic cancer care.

Conditions treated byProfessor Liu Shuangyou

  • Refractory hematologic malignancies
  • Recurrent hematologic malignancies
  • Hematologic cancers requiring CAR-T cell immunotherapy

Area of Interest

  • CAR-T cell immunotherapy
  • Diagnosis and treatment of refractory and recurrent hematologic malignancies
  • Clinical and translational research in haematology

Qualification

  • Doctor of Medicine (MD), Heidelberg University, Germany
  • Global Team of Board Certified Surgeons and Medical Specialists
  • Written Second Opinion report delivered within 5 days
  • Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Professor Liu Shuangyou on our platform

RESEARCH PAPERS AND PUBLICATIONS (1)

  • Professor Liu Shuangyou has published research in both domestic and international medical journals, including the Blood Cancer Journal, American Journal of Haematology, and the European Journal of Cancer, and has delivered oral presentations and poster presentations at major international conferences such as ASH, EHA, and EBMT.

Share Your Experience about Dr. Professor Liu Shuangyou

PROCEDURES

  • CAR-T

FREQUENTLY ASKED QUESTIONS

Is Professor Liu Shuangyou doing teleconsultation on the MediGence platform?
Professor Liu Shuangyou is available to teleconsult on the MediGence platform.
How long is the consultation?
The consultation can last from 15 to 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.
How soon can the consultation be organised?
We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.
Is a follow-up consultation included in the consultation price?
No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.
How do I share my medical record with the doctor for review?
The option to share your medical records is available between the steps of the form provided to you on the website.
Can I book my procedure with the doctor post-consultation?
Yes. If you are satisfied with the consultation, you can go ahead with treatment packages for your diagnosis with the help of our case managers.
Can you get an estimate for the procedure?
Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

FAQ's Related to Hematologist

What does a hemato-oncologist do?
A hemato-oncologist is a medical doctor who specialises in the diagnosis and treatment of blood cancers and blood disorders, such as leukaemia, lymphoma, multiple myeloma, and related conditions. They manage cancer care using therapies like chemotherapy, immunotherapy, targeted therapy, and cellular treatments, including CAR-T therapy and stem cell transplantation.
What is hemato-oncology?
Hemato-oncology is a medical speciality that combines haematology (blood disorders) and oncology (cancer care). It focuses on treating cancers of the blood, bone marrow, and lymphatic system using advanced, personalised, and often multidisciplinary treatment approaches.
When should I see a hemato-oncologist?
You should see a hemato-oncologist if you have been diagnosed with a blood cancer, have abnormal blood test results, persistent symptoms such as unexplained fatigue or infections, or need specialised care for relapsed, refractory, or complex blood disorders.
Are hemato-oncology treatments painful?
Most treatments are well-managed and closely monitored. While some therapies may cause temporary side effects, hemato-oncologists focus on symptom control, supportive care, and pain management to ensure patient comfort throughout treatment.
Is hemato-oncology treatment safe?
Yes. Treatments are evidence-based and carefully tailored to each patient. Hemato-oncologists use the latest clinical guidelines and advanced therapies to maximise effectiveness while minimising side effects and risks.
How should I prepare for a hemato-oncology consultation?
Bring your blood test reports, biopsy results, imaging studies, treatment history, and medication list. Being prepared helps your hemato-oncologist design the most appropriate and effective treatment plan for your condition.

Reviewer

Dr. Vishwas Kaushik
Dr. Vishwas Kaushik

MBBS, MD

7 Years of Experience

Dr. Vishwas Kaushik is a qualified medical professional holding an MBBS from the prestigious Belgorod State University, Russia, with a strong foundation in clinical medicine and healthcare practice. His comprehensive medical training has equipped him with a profound understanding of evidence-based clinical practices, patient-centered care, and the evolving landscape of modern medicine. With a keen interest in medical research and scientific communication, he consistently translates complex clinical concepts into clear, accurate, and accessible content for diverse audiences. His work reflects a deep commitment to advancing medical knowledge, delivering impactful healthcare insights, and bridging the gap between clinical expertise and accessible medical communication. View More

Last Reviewed - January 2026

Author

Fauzia Zeb Fatima
Fauzia Zeb Fatima

M.Pharm

4 Years of Experience

Fauzia Zeb is a distinguished medical and scientific content writer with a robust academic foundation in pharmaceutical sciences, holding a B.Pharm and M.Pharm degree from prestigious institutions, including MIT and Jamia Hamdard University. Her comprehensive expertise in pharmacology, clinical sciences, and biomedical research enables her to translate complex medical and scientific concepts into precise, evidence-based content tailored for diverse audiences. Specializing in peer-reviewed articles, clinical blog posts, and research-driven publications, she demonstrates a consistent ability to bridge the gap between advanced medical science and accessible, audience-specific communication.. View More